B. A. Avazbekov (1), G. M. Tulaboeva (2), X. X. Tursunov (3), Sh. S. Sobirova (4)
Effective treatment of atrial fibrillation (AF) must begin with the initiation of anticoagulant therapy (ACT) [1]. A key component of managing patients with both AF and heart failure (HF)—especially with the growing prevalence of procedures like cardioversion or catheter ablation (CA)—is the accurate prescription of ACT and continuous monitoring throughout the treatment process.